Veterinary Point Of Care Diagnostics Market Report Scope
According to a recent report published by Future Market Insights, the Global Veterinary Point-Of-Care Diagnostics Industry is on the brink of a significant expansion, showcasing promising prospects in the years ahead. The market is anticipated to reach a noteworthy value of US$1.3 billion by the end of 2021, setting the stage for an impressive trajectory from 2022 to 2032.
One of the main drivers of this growth is the increasing focus on companion animal health. Companion animals, which include pets such as dogs, cats, and birds, are expected to generate the majority of revenue within the market. From 2022 to 2032, companion animals are projected to represent an absolute dollar opportunity of nearly US$3.1 billion, indicating a significant potential for growth in this area.
Government actions such as stay-at-home recommendations and social distancing procedures forced market participants to change, reduce, or halt operating activities during the first half of 2020. Veterinary clinics and hospitals in multiple areas reported low patient volumes, with some focusing solely on emergency patients.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14769
Owners of animals, on the other hand, continued to receive veterinary care because it was widely regarded as an “important” service. The blood/plasma/serum category, which accounted for more than 40.0 percent of total revenue, is expected to drive market growth. Regular blood testing is recommended by Kirkwood Animal Hospital in the United States as an important part of a companion animal’s overall wellness regimen. Blood tests are less expensive and less invasive than medical treatment.
Dogs and cats dominate the pet population in the United States, according to the American Pet Products Association’s National Pet Owners Survey for 2019 to 2020. (APPA). Americans are expected to spend more than $100 billion on pets by 2020. It is estimated that 31.4 billion US dollars were spent solely on veterinary care and product sales. According to the APPA survey, dog and cat owners spent an average of $426 and 214 on surgical vet visits, respectively, and 212 and 160 on routine vet visits.
Key Takeaways from the Global Veterinary Point Of Care Diagnostics Industry Study
The global veterinary point-of-care diagnostics market is expected to reach US$6.3 billion by 2032.
North America is expected to contribute more than 30% of market revenue in 2022.
Companion animals are expected to contribute the most revenue with a CAGR of 15.5%.
The Consumables, Reagents, and Kits segment is expected to grow at the fastest rate, with a 15.8% CAGR.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14769
Global Veterinary Point Of Care Diagnostics Industry Competitive Landscape
This market is dominated by some regional and global players. Companies employ a variety of strategies to remain competitive.
Heska Corp. announced the acquisition of Scil Animal Care Company GmbH, a provider of veterinary point-of-care diagnostics, in April 2020.
IDEXX Laboratories announced the release of a canine Progesterone Test for the Catalyst One Chemistry and Catalyst Dx Analyzers in 2019.
Fujifilm Sonosite announced a partnership with Partners Healthcare in 2019.
Stablelab, a compact point-of-care blood test for horses, was introduced by Zoetis Inc. in 2019.
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Global Veterinary Point Of Care Diagnostics Industry, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights based on end-users across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Future Market Insights’ Domain Knowledge in Healthcare Division
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/14769
Market Segments Covered In Global Veterinary Point Of Care Diagnostics Industry Analysis
By Animal Type:
Companion Animals
Dogs
Cats
Horses
Other Companion Animals
Livestock Animals
Cattle
Swine
Poultry
Other Livestock Animals
By Product Type:
Consumables, Reagents, & Kits
Instruments & Devices
By Sample Type:
Blood/Plasma/Serum
Urine
Fecal
Other Sample Type
By Testing Type:
Hematology
Diagnostic Imaging
Bacteriology
Virology
Cytology
Clinical Chemistry
Parasitology
Serology
Other Testing Type
Veterinary Point Of Care Diagnostics Market Report Scope
According to a recent report published by Future Market Insights, the Global Veterinary Point-Of-Care Diagnostics Industry is on the brink of a significant expansion, showcasing promising prospects in the years ahead. The market is anticipated to reach a noteworthy value of US$1.3 billion by the end of 2021, setting the stage for an impressive trajectory from 2022 to 2032.
One of the main drivers of this growth is the increasing focus on companion animal health. Companion animals, which include pets such as dogs, cats, and birds, are expected to generate the majority of revenue within the market. From 2022 to 2032, companion animals are projected to represent an absolute dollar opportunity of nearly US$3.1 billion, indicating a significant potential for growth in this area.
Government actions such as stay-at-home recommendations and social distancing procedures forced market participants to change, reduce, or halt operating activities during the first half of 2020. Veterinary clinics and hospitals in multiple areas reported low patient volumes, with some focusing solely on emergency patients.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14769
Owners of animals, on the other hand, continued to receive veterinary care because it was widely regarded as an “important” service. The blood/plasma/serum category, which accounted for more than 40.0 percent of total revenue, is expected to drive market growth. Regular blood testing is recommended by Kirkwood Animal Hospital in the United States as an important part of a companion animal’s overall wellness regimen. Blood tests are less expensive and less invasive than medical treatment.
Dogs and cats dominate the pet population in the United States, according to the American Pet Products Association’s National Pet Owners Survey for 2019 to 2020. (APPA). Americans are expected to spend more than $100 billion on pets by 2020. It is estimated that 31.4 billion US dollars were spent solely on veterinary care and product sales. According to the APPA survey, dog and cat owners spent an average of $426 and 214 on surgical vet visits, respectively, and 212 and 160 on routine vet visits.
Key Takeaways from the Global Veterinary Point Of Care Diagnostics Industry Study
The global veterinary point-of-care diagnostics market is expected to reach US$6.3 billion by 2032.
North America is expected to contribute more than 30% of market revenue in 2022.
Companion animals are expected to contribute the most revenue with a CAGR of 15.5%.
The Consumables, Reagents, and Kits segment is expected to grow at the fastest rate, with a 15.8% CAGR.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14769
Global Veterinary Point Of Care Diagnostics Industry Competitive Landscape
This market is dominated by some regional and global players. Companies employ a variety of strategies to remain competitive.
Heska Corp. announced the acquisition of Scil Animal Care Company GmbH, a provider of veterinary point-of-care diagnostics, in April 2020.
IDEXX Laboratories announced the release of a canine Progesterone Test for the Catalyst One Chemistry and Catalyst Dx Analyzers in 2019.
Fujifilm Sonosite announced a partnership with Partners Healthcare in 2019.
Stablelab, a compact point-of-care blood test for horses, was introduced by Zoetis Inc. in 2019.
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Global Veterinary Point Of Care Diagnostics Industry, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights based on end-users across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Future Market Insights’ Domain Knowledge in Healthcare Division
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/14769
Market Segments Covered In Global Veterinary Point Of Care Diagnostics Industry Analysis
By Animal Type:
Companion Animals
Dogs
Cats
Horses
Other Companion Animals
Livestock Animals
Cattle
Swine
Poultry
Other Livestock Animals
By Product Type:
Consumables, Reagents, & Kits
Instruments & Devices
By Sample Type:
Blood/Plasma/Serum
Urine
Fecal
Other Sample Type
By Testing Type:
Hematology
Diagnostic Imaging
Bacteriology
Virology
Cytology
Clinical Chemistry
Parasitology
Serology
Other Testing Type
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
